Press releases
30 March 2012 - The Belgian Pharmaceutical Conference : latest update on clinical studies in Belgium and new recommendations for the decision makers
Since the bumper year of 2008, systematically fewer patients are able to take part in clinical studies in Belgium. The drop in Belgium is in line with the decline of clinical studies in Europe. This trend is severely impairing the number of patients who benefit from taking part in the earliest stage of treatment involving innovative medicines. After a constant rise of the number of clinical studies in Belgium over the years, this downward spiral is sounding the alarm bell. High time to act. During the Belgian Pharmaceutical Conference PricewaterhouseCoopers' Ingrid Maes, together with the FAMHP's dr. Greet Musch, who is chairing the second plenary session, presents not only an in-depth analysis of the state of affairs of clinical studies in Belgium, she also puts forward recommendations aimed at safeguarding this type of research that is essential for Belgian patients and our knowledge-based economy.
>> Read more (Nl) >> Read more (Fr)
21 March 2012 – Societal focus on medicines : Pharma/Healthcare and the Econoshock
The economic upheavals of the recent past will demand some significant adjustments from the pharmaceutical industry. “The next pharma generation will have to adapt to the 2030 healthcare ecosystem”, confirms expert Geert Noels, CEO of Econopolis. Different strategies will be highlighted during the Conference to prepare for this economic challenges.
17 February 2012 – 'The Impatient Patient©' : discover the topic during the Belgian Pharmaceutical Conference on April 17, 2012.
The organizers BeAPP, BAPU and pharma.be present the final program and an overview of the top notch speakers.
19 January 2012 - New website highlights the Belgian pharmaceutical conference 2012 : main focus on 'The Impatient Patient©'
pharma.be and BeAPP announce the launch of this new website of the Belgian pharmaceutical conference which will be held in Brussels on April 17th, 2012. The website offers immediate access to all info about the conference : the Umbrella theme 'The Impatient Patient©', the program, the top notch speakers, the top location and other practicalities. On April 17th you will discover on a national and European level, together with all healthcare partners, more about the growing tendency for patients to become more outspoken, critical and informed.
Press relations
 |
For in-depth information concerning the different topics that will be elaborated during the Belgian pharmaceutical conference on April 17 2012 or for an interview with one of the speakers, we invite you to contact Christine Vanormelingen, Communication Director and Spokeswoman of pharma.be |
Christine Vanormelingen
Communication Director and Spokeswoman of pharma.be
Mail: cvo@pharma.be
